Target intelligence / Profile preview

Peritoneal membrane transport system

Molecular classification
Transporter, Aquaporin, Paracellular pathway, Endothelial barrier
01

Overview

The peritoneal membrane transport system represents the physiological mechanism responsible for fluid and waste exchange during peritoneal dialysis (PD). This system is conceptualized by the 'Three-Pore Model,' which identifies three distinct pathways for transport across the peritoneal capillary endothelium: ultra-small pores (Aquaporin-1), small pores (intercellular clefts), and large pores (venular gaps) [1, 2]. Aquaporin-1 (AQP1) is the primary molecular target for water transport, facilitating approximately 50% of ultrafiltration driven by crystalloid osmotic gradients like glucose [3, 4]. Small pores allow for the diffusion of small solutes like urea and creatinine, while large pores permit the passage of macromolecules such as albumin [2]. Chronic exposure to bioincompatible dialysis fluids can lead to structural remodeling, including peritoneal fibrosis and neoangiogenesis, which results in ultrafiltration failure—a major cause of PD technique failure [1, 3]. Therapeutic interventions focus on using osmotic agents like icodextrin to bypass AQP1-mediated transport or experimental agents like SGLT2 inhibitors to preserve membrane integrity [2, 6]. Citations: [1] Rippe B. (1993) PMID: 8395256; [2] Devuyst O, et al. (2002) PMID: 12138152; [3] Morelle J, et al. (2015) PMID: 26224789; [4] Ni J, et al. (2001) PMID: 11298774; [6] Martus G, et al. (2021) PMID: 33479017.

Other names
Three-pore modelPeritoneal membrane water and solute transport pathwaysPeritoneal barrierPeritoneal transport pathways
02

Mechanism of action

Generation of crystalloid or colloid osmotic gradients to drive water and solute flux through specific pore populations, including Aquaporin-1 and intercellular clefts [1, 2].

03

Biological functions

UltrafiltrationSolute diffusionOsmosisFluid homeostasisConvection
04

Disease associations

End-stage renal diseaseUltrafiltration failurePeritoneal fibrosisEncapsulating peritoneal sclerosisPeritonitis
05

Safety considerations

Peritoneal membrane failureGlucose-mediated toxicityPeritonitis-related scarringEncapsulating peritoneal sclerosisLoss of ultrafiltration capacity
06

Interacting drugs

Glucose

5 more in the full profile.

07

Biomarkers

Peritoneal Equilibration Test (PET)D/P creatinine ratioNet ultrafiltration volumeFree water transportCA-125

Beyond the preview

Go deeper on Peritoneal membrane transport system.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Peritoneal membrane transport system.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call